Singapore: The Korean government announced plans to boost the fast growing biotech sector of Korea at the 11th President...
Before joining the family business of Green Cross in 1979, Mr Il-Sup Huh, the fifth son in the family, served the Korean...
Singapore: Dong-A Socio Holdings inaugurated their DM Bio plant dedicated to manufacturing biosimilar medicines and medi...
Singapore: Sigma-Aldrich's custom manufacturing and services business unit, SAFC, has signed an agreement with Seoul-bas...
According to the Global Burden of Disease and Risk Factors (World Bank Publications, 2006), infectious diseases are one ...
Many companies in India, China and to an extent Korea have established a strong position in contract manufacturing of ac...
In 2007, Dabur Pharma, one of India's leading manufacturers of anti-cancer drugs, launched Nanoxel, a novel drug deliver...
Singapore: Doctors at the Samsung Medical center have revealed a new group of drug resistant pathogens that had affected...
Singapore: Korea is all set to host international bio exposition showcasing a glimpse into the future of biotechnology a...
Singapore: Affymetrix and Korean genomics-based biotech company, DNA Link, signed a Powered by Affymetrix (PbA) Programm...
Singapore: The Korea Drug Development Fund (KDDF) has chosen PAREXEL International, a leading global biopharmaceutical s...
Singapore: Global Pharmaceutical company, Merck, and Samsung Bioepis, a joint venture between Samsung Biologics and Biog...
Singapore: RNL BIO, Korea-based stem cell biotechnology company, has filed an Investigational New Drug application (IND)...
‎Singapore: Supply chain firm, Marken has appointed Mr Michael Culme-Seymour as VP, Asia Pacific, effective Octobe...
Singapore: Asia share of global GDP, measured in purchasing power, has increased from 26.8 percent in 2001 to 33.8 perce...
Singapore: According to Millennium Research Group (MRG), a provider of market intelligence on medical technology, the em...
Singapore: Asian pharmaceutical firm, Mundipharma, has promoted the general manager of Mundipharma Korea, Mr John Lee, t...
Singapore: South Korean company Green Cross is building a plasma derivatives plant (worth $68 million) in Bangkok, Thail...
